Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
YouTube
Podcasts
Zoom Journal Club
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 31, Issue Suppl 3
791 Effectiveness and safety of lenvatinib and pembrolizumab (LenPem) therapy for endometrial cancer (EC): Results from a Russian multicenter database
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Endometrial cancer
791 Effectiveness and safety of lenvatinib and pembrolizumab (LenPem) therapy for endometrial cancer (EC): Results from a Russian multicenter database
Free
Online download statistics by month:
Online download statistics by month: October 2021 to March 2024
Abstract
Full
Pdf
Oct 2021
63
0
13
Nov 2021
42
0
10
Dec 2021
30
0
8
Jan 2022
86
0
17
Feb 2022
23
0
4
Mar 2022
14
0
4
Apr 2022
6
0
4
May 2022
53
0
12
Jun 2022
17
0
5
Jul 2022
18
0
4
Aug 2022
13
0
6
Sep 2022
56
0
12
Oct 2022
20
0
13
Nov 2022
37
0
4
Dec 2022
45
0
5
Jan 2023
51
0
9
Feb 2023
22
0
0
Mar 2023
21
0
4
Apr 2023
29
0
4
May 2023
18
0
2
Jun 2023
16
0
3
Jul 2023
20
0
7
Aug 2023
12
0
4
Sep 2023
8
0
2
Oct 2023
17
0
0
Nov 2023
25
0
2
Dec 2023
19
0
4
Jan 2024
19
0
0
Feb 2024
52
0
5
Mar 2024
18
0
3
Total
870
0
170
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in via your Society
Select your society
ESGO
IGCS
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?